Gelmetix
the developer of a first-in-class polymer treatment for chronic lower back pain
Gelmetix has raised €5.8M across 1 funding round from 1 investor, most recently a Series C round in May 2021. Based in Manchester, UK; active in Healthtech. Data as of 28 Oct 2026.
Manchester, UKwww.gelmetix.com ↗
Total raised
€5.8M
€5,808,348
Funding rounds
1
Investors
1
distinct backers
Active since
2021-05
latest 2021-05
Funding by year
EUR raised per yearGelmetix — funding by year — interactive chart.
Data table
| Gelmetix — funding by year | |
|---|---|
| 2021 | €5.8M |
Signals
High confidenceRaise-next likelihood9
base rate 50% for Series C
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-05-14 | Series C | €5.8M | Seneca Partners | View deal → |